Key facts
- Echopoint Medical’s last known valuation is $10.8M (Mar 2026).
- It has raised $11.4M across 1 recorded rounds; the latest was Seed Round ($250K) in Nov 2025.
- Notable investors include Innovate UK, Parkwalk Advisors, AlbionVC, HeartX Accelerator, P4 Precision — 9 tracked in total.
- Echopoint Medical has filed 1 Form D with the SEC, most recently Dec 2025 ($250K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Echopoint Medical
Funding rounds
1 roundsAbout Echopoint Medical
Developer of cardiovascular devices designed to treat patients and to transform coronary diagnostics. The company's platform incorporates fiber optic sensing technology, integrated pressure and flow measurement capabilities, real-time physiological data acquisition, compatibility with standard catheterization laboratory workflows, rapid exchange microcatheter design, and software supported analysis of coronary flow reserve, enabling interventional cardiologists and cardiovascular care providers to obtain comprehensive diagnostic information during minimally invasive procedures to support more accurate clinical decision- making and targeted treatment planning.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 16
- Website
- echopointmedical.com/
- Ownership
- Privately Held (backing)
Echopoint Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Echopoint Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Echopoint Medical in its N-PORT filings yet. We sweep new filings monthly.